Business
IMM RNS Posting of RA and Notice of AGM 30 June 23
IMM RNS Posting of RA and Notice of AGM 30 June 23.
About this update from Immupharma Plc
[{"type":"text","content":"\n\n \n\n \n \n \nRNS: RELEASE 6 June 2023\nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nNotice of AGM & Annual Report & Accounts\n \nImmuPharma PLC (LSE AIM: IMM), the specialist drug discovery and development company, confirms that the Notice of Annual General Meeting (\"AGM\") has today been posted to shareholders. The Annual Report and Accounts for the year ended 31 December 2022 has also been posted to shareholders today.\n \nThese documents will be available shortly, in electronic form, for download on the Company's website www.immupharma.co.uk.\n \nImmuPharma's AGM will be held on Friday 30th June 2023 @ 11:00am (BST) at: One Bartholomew Close, London, EC1A 7BL.\nEnds\n\n\n\n\nFor further information please contact:\n \n\n\n\n\nImmuPharma PLC (www.immupharma.com)\nTim McCarthy, Chairman and Chief Executive Officer\n\n\n+ 44 (0) 207 206 2650\n\n\n\n\nLisa Baderoon, Head of Investor Relations\n\n\n+ 44 (0) 7721 413496\n \n \n\n\n\n\nSPARK Advisory Partners Limited (NOMAD)\nNeil Baldwin\n \nStanford Capital Partners (Joint Broker)\nPatrick Claridge, John Howes, Bob Pountney\n \nSI Capital (Joint Broker)\nNick Emerson\n\n\n+44 (0) 203 368 3550\n \n \n+44 (0) 203 815 8880\n \n \n+44 (0) 1483 413500\n \n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n \nNotes to Editors\nAbout ImmuPharma PLC\nImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company th...